2019
DOI: 10.1111/anae.14603
|View full text |Cite
|
Sign up to set email alerts
|

Medical device regulation: the need for clinical vigilance and oversight

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(12 citation statements)
references
References 17 publications
0
11
0
Order By: Relevance
“…In their 2019 commentary on medical device regulation, Charlesworth and van Zundert argued that while medical device manufacturers may posit that it is too costly, time-consuming, and impractical to generate evidence on devices from large studies, primary research is undeniably critical to ensuring that large-scale implementation will be beneficial. 22 Relatedly, a major finding from this review is that further research on portable ultrasound devices-in particular their accuracy and acceptability when used in antenatal care contexts-are needed to guide decision-making around selection and procurement of ultrasound models. Since 2016, WHO has recommended that all women should have an ultrasound prior to 24 weeks' gestation; however, the coverage of ultrasound use remains limited in many countries.…”
Section: Discussionmentioning
confidence: 99%
“…In their 2019 commentary on medical device regulation, Charlesworth and van Zundert argued that while medical device manufacturers may posit that it is too costly, time-consuming, and impractical to generate evidence on devices from large studies, primary research is undeniably critical to ensuring that large-scale implementation will be beneficial. 22 Relatedly, a major finding from this review is that further research on portable ultrasound devices-in particular their accuracy and acceptability when used in antenatal care contexts-are needed to guide decision-making around selection and procurement of ultrasound models. Since 2016, WHO has recommended that all women should have an ultrasound prior to 24 weeks' gestation; however, the coverage of ultrasound use remains limited in many countries.…”
Section: Discussionmentioning
confidence: 99%
“…MD manufacturers must ensure traceability of all customer complaints they receive and establish documentation of procedures to analyze and evaluate these complaints which make it possible to notify vigilance procedures if need be [33]. Health professionals, for their part, should be aware of the importance of reporting an AR, particularly with the emergence of new situations, and this by institutionally encouraging formal education on patient safety and MD regulation [34]. Also, interested parties , who are entrusted with MD use, be they patients or consumers in this system, should assigned a role and involved in the conservation of the quality of their health.…”
Section: Regulations and Proceduresmentioning
confidence: 99%
“…Harmonization of National and International Regulations could serve as a safety net that would ensure patients and users throughout the world have access to the same level of design and safety controls. This might be able to prevent situations such as the PIP breast implants scandal or the DePuy MoM hip replacement recalls [9,34,38].…”
Section: Overview Of Design-related Regulationsmentioning
confidence: 99%
“…During this stage, MD design control is performed as part of the QMS requirements [ 35 , 37 , 53 , 55 ]. In practice, an MD’s design aims to define the necessary specifications and exclude all potential hazards related to the intended use through the risk assessment process and conformity with national and international safety requirements [ 31 , 33 , 35 , 36 , 38 ]. Safe and effective MD design therefore begins as early as the product definition phase, even before product requirements and architecture have been specified [ 83 ].…”
Section: Overview Of Design-related Regulationsmentioning
confidence: 99%
See 1 more Smart Citation